Charles J. Meyers - Jan 17, 2023 Form 4 Insider Report for EQUINIX INC (EQIX)

Signature
/s/ Samantha Lagocki, POA
Stock symbol
EQIX
Transactions as of
Jan 17, 2023
Transactions value $
-$5,212,164
Form type
4
Date filed
1/19/2023, 03:39 PM
Previous filing
Sep 8, 2022
Next filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EQIX Common Stock Options Exercise $0 +5.26K +70.69% $0.00 12.7K Jan 17, 2023 Direct
transaction EQIX Common Stock Options Exercise $0 +3.81K +30% $0.00 16.5K Jan 17, 2023 Direct
transaction EQIX Common Stock Options Exercise $0 +3.71K +22.47% $0.00 20.2K Jan 17, 2023 Direct
transaction EQIX Common Stock Options Exercise $0 +3.76K +18.6% $0.00 24K Jan 17, 2023 Direct
transaction EQIX Common Stock Sale -$70K -100 -0.42% $699.58 23.9K Jan 18, 2023 Direct F1, F2
transaction EQIX Common Stock Sale -$487K -695 -2.91% $700.62 23.2K Jan 18, 2023 Direct F1, F3
transaction EQIX Common Stock Sale -$495K -705 -3.04% $701.77 22.5K Jan 18, 2023 Direct F1, F4
transaction EQIX Common Stock Sale -$144K -205 -0.91% $702.65 22.3K Jan 18, 2023 Direct F1, F5
transaction EQIX Common Stock Sale -$880K -1.25K -5.61% $704.01 21K Jan 18, 2023 Direct F1, F6
transaction EQIX Common Stock Sale -$882K -1.25K -5.95% $705.26 19.8K Jan 18, 2023 Direct F1, F7
transaction EQIX Common Stock Sale -$471K -667 -3.37% $706.15 19.1K Jan 18, 2023 Direct F1, F8
transaction EQIX Common Stock Sale -$265K -375 -1.96% $707.04 18.7K Jan 18, 2023 Direct F1, F9
transaction EQIX Common Stock Sale -$17.7K -25 -0.13% $707.86 18.7K Jan 18, 2023 Direct F1
transaction EQIX Common Stock Sale -$74.5K -105 -0.56% $709.34 18.6K Jan 18, 2023 Direct F1, F10
transaction EQIX Common Stock Sale -$782K -1.1K -5.91% $711.05 17.5K Jan 18, 2023 Direct F1, F11
transaction EQIX Common Stock Sale -$143K -200 -1.14% $713.83 17.3K Jan 18, 2023 Direct F1, F12
transaction EQIX Common Stock Sale -$286K -400 -2.31% $715.34 16.9K Jan 18, 2023 Direct F1, F13
transaction EQIX Common Stock Sale -$215K -300 -1.78% $716.04 16.6K Jan 18, 2023 Direct F1, F14

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EQIX Restricted Stock Unit Award $0 +5.26K $0.00 5.26K Jan 17, 2023 Common Stock 5.26K $0.00 Direct F15, F16
transaction EQIX Restricted Stock Unit Options Exercise $0 -5.26K -100% $0.00* 0 Jan 17, 2023 Common Stock 5.26K $0.00 Direct F15, F16
transaction EQIX Restricted Stock Unit Options Exercise $0 -3.81K -100% $0.00* 0 Jan 17, 2023 Common Stock 3.81K $0.00 Direct F16, F17
transaction EQIX Restricted Stock Units Options Exercise $0 -3.71K -50% $0.00 3.71K Jan 17, 2023 Common Stock 3.71K $0.00 Direct F16, F18
transaction EQIX Restricted Stock Unit Options Exercise $0 -3.76K -33.34% $0.00 7.52K Jan 17, 2023 Common Stock 3.76K $0.00 Direct F16, F19
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold pursuant to a 10b5-1 Trading Plan in order to raise funds to pay the required withholding tax pursuant to the vesting of RSUs.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $698.85 to $699.705, inclusive. The reporting person undertakes to provide to Equinix, Inc, any security holder of Equinix Inc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 3 through 14 to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $700.21 to $701.175 inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $701.32 to $702.25 inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $702.51 to $703.1298 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $703.54 to $704.49 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $704.66 to $705.66 inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $705.69 to $706.53 inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $706.7375 to $707.36 inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $709.31 to $709.94 inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $710.69 to $711.27 inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $713.35 to $714.30 inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $714.84 to $715.63 inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $715.85 to $716.42 inclusive.
F15 On February 26, 2020, the reporting person was granted performance restricted stock units, the vesting of which was subject to both continued service and the degree to which a relative Total Shareholder Return target was attained for the period January 1, 2020 to December 31, 2022. The Compensation Committee certified that the payout for this award would be 92.02% (out of a possible 100%) of the target to the reporting person based on the degree to which Equinix performed against the Russell 1000 Index.
F16 Restricted stock unit award expires upon reporting person's termination of service.
F17 Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2021 and an additional 33.33% of the RSUs will each vest on January 15, 2022 and January 15, 2023.
F18 Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2022 and an additional 33.33% of the RSUs will each vest on January 15, 2023 and January 15, 2024.
F19 Vesting is dependent upon continuous active service as an employee, consultant or director of the Company or a subsidiary of the Company (Service) throughout the vesting period. The Restricted Stock Units shall vest as follows: 33.33% of the RSUs vested on January 15, 2023 and an additional 33.33% of the RSUs will each vest on January 15, 2024 and January 15, 2025.